CN109820824A - 一种用于促进皮肤创伤愈合的辣椒碱液晶纳米喷雾制剂及其制备方法 - Google Patents
一种用于促进皮肤创伤愈合的辣椒碱液晶纳米喷雾制剂及其制备方法 Download PDFInfo
- Publication number
- CN109820824A CN109820824A CN201910263443.2A CN201910263443A CN109820824A CN 109820824 A CN109820824 A CN 109820824A CN 201910263443 A CN201910263443 A CN 201910263443A CN 109820824 A CN109820824 A CN 109820824A
- Authority
- CN
- China
- Prior art keywords
- liquid crystal
- capsaicine
- preparation
- wound healing
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 105
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 title claims abstract description 90
- 229960002504 capsaicin Drugs 0.000 title claims abstract description 89
- 238000002360 preparation method Methods 0.000 title claims abstract description 71
- 239000007921 spray Substances 0.000 title claims abstract description 67
- 230000029663 wound healing Effects 0.000 title claims abstract description 43
- 206010072170 Skin wound Diseases 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 31
- 239000002105 nanoparticle Substances 0.000 claims abstract description 37
- 239000000463 material Substances 0.000 claims abstract description 33
- 229920001661 Chitosan Polymers 0.000 claims abstract description 21
- 239000006184 cosolvent Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 claims abstract description 13
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 13
- DRAWQKGUORNASA-UHFFFAOYSA-N (2-hydroxy-3-octadec-9-enoyloxypropyl) octadec-9-enoate Chemical compound CCCCCCCCC=CCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCC=CCCCCCCCC DRAWQKGUORNASA-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004094 surface-active agent Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 235000019441 ethanol Nutrition 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000002243 precursor Substances 0.000 claims description 7
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 6
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 6
- 229940093471 ethyl oleate Drugs 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 22
- 229940079593 drug Drugs 0.000 abstract description 11
- 238000009472 formulation Methods 0.000 abstract description 9
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract description 3
- 235000018417 cysteine Nutrition 0.000 abstract description 3
- 238000002955 isolation Methods 0.000 abstract description 3
- 239000006185 dispersion Substances 0.000 abstract description 2
- 230000001408 fungistatic effect Effects 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 description 38
- 206010052428 Wound Diseases 0.000 description 37
- 230000000052 comparative effect Effects 0.000 description 15
- 102100040247 Tumor necrosis factor Human genes 0.000 description 14
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 13
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 230000036961 partial effect Effects 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- 102000000589 Interleukin-1 Human genes 0.000 description 9
- 108010002352 Interleukin-1 Proteins 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000126 substance Chemical group 0.000 description 3
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 description 3
- 208000031636 Body Temperature Changes Diseases 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000009416 jing wan hong Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003232 mucoadhesive effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910263443.2A CN109820824B (zh) | 2019-04-02 | 2019-04-02 | 一种用于促进皮肤创伤愈合的辣椒碱液晶纳米喷雾制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910263443.2A CN109820824B (zh) | 2019-04-02 | 2019-04-02 | 一种用于促进皮肤创伤愈合的辣椒碱液晶纳米喷雾制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109820824A true CN109820824A (zh) | 2019-05-31 |
CN109820824B CN109820824B (zh) | 2020-10-20 |
Family
ID=66874006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910263443.2A Expired - Fee Related CN109820824B (zh) | 2019-04-02 | 2019-04-02 | 一种用于促进皮肤创伤愈合的辣椒碱液晶纳米喷雾制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109820824B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113092406A (zh) * | 2021-04-08 | 2021-07-09 | 晨光生物科技集团股份有限公司 | 一种快速预判辣椒红外观品质变化的方法 |
CN113440435A (zh) * | 2021-07-07 | 2021-09-28 | 珀莱雅化妆品股份有限公司 | 一种皮肤抗衰老组合物的制备方法 |
CN115040500A (zh) * | 2022-04-08 | 2022-09-13 | 广州新济生物医药研究院有限公司 | 抗菌纳米颗粒、溶致液晶前体溶液喷雾敷料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108078957A (zh) * | 2017-12-07 | 2018-05-29 | 广东医科大学 | 一种用于促进皮肤创伤愈合的辣椒碱立方液晶纳米粒的制备方法及其应用 |
CN108403637A (zh) * | 2018-04-20 | 2018-08-17 | 武汉百纳礼康生物制药有限公司 | 一种口腔喷雾制剂及其制备方法 |
CN108420787A (zh) * | 2018-05-15 | 2018-08-21 | 华中科技大学鄂州工业技术研究院 | 一种细胞因子类创伤修复药物溶致液晶凝胶纳米制剂及其制备方法 |
-
2019
- 2019-04-02 CN CN201910263443.2A patent/CN109820824B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108078957A (zh) * | 2017-12-07 | 2018-05-29 | 广东医科大学 | 一种用于促进皮肤创伤愈合的辣椒碱立方液晶纳米粒的制备方法及其应用 |
CN108403637A (zh) * | 2018-04-20 | 2018-08-17 | 武汉百纳礼康生物制药有限公司 | 一种口腔喷雾制剂及其制备方法 |
CN108420787A (zh) * | 2018-05-15 | 2018-08-21 | 华中科技大学鄂州工业技术研究院 | 一种细胞因子类创伤修复药物溶致液晶凝胶纳米制剂及其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113092406A (zh) * | 2021-04-08 | 2021-07-09 | 晨光生物科技集团股份有限公司 | 一种快速预判辣椒红外观品质变化的方法 |
CN113440435A (zh) * | 2021-07-07 | 2021-09-28 | 珀莱雅化妆品股份有限公司 | 一种皮肤抗衰老组合物的制备方法 |
CN115040500A (zh) * | 2022-04-08 | 2022-09-13 | 广州新济生物医药研究院有限公司 | 抗菌纳米颗粒、溶致液晶前体溶液喷雾敷料及其制备方法 |
CN115040500B (zh) * | 2022-04-08 | 2024-04-30 | 广州新济生物医药研究院有限公司 | 抗菌纳米颗粒、溶致液晶前体溶液喷雾敷料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109820824B (zh) | 2020-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104427976B (zh) | 疏水的活性成分的储库制剂及其制备方法 | |
CN109820824A (zh) | 一种用于促进皮肤创伤愈合的辣椒碱液晶纳米喷雾制剂及其制备方法 | |
TW200526252A (en) | Surfactant-based gel as an injectable, sustained drug delivery vehicle | |
JP2001508756A (ja) | 非ポリマー持続性解離供給システム | |
CN105120839B (zh) | 可注射长效局麻药半固体制剂及其组成成分 | |
KR20070085773A (ko) | 사마귀 치료를 위한 장치와 방법 | |
TW200524631A (en) | Excipients in drug delivery vehicles | |
CN108420787B (zh) | 一种细胞因子类创伤修复药物溶致液晶凝胶纳米制剂及其制备方法 | |
JP2008523101A (ja) | 爪ユニットの状態を治療するための組成物および方法 | |
JP2009538307A (ja) | ネイルユニットの状態を治療するための組成物および方法 | |
CN103736080B (zh) | 用于伤口愈合的制剂、制备方法及其用途 | |
Suman et al. | Emugel for topical drug delivery: A novel approach | |
CN113679658A (zh) | 用于皮肤止痒抗过敏治疗的可溶性微针贴片及其制备方法 | |
Sumner et al. | Development and evaluation of a novel topically applied sildenafil citrate hydrogel and its influence on wound healing in dogs | |
CN102365075A (zh) | 医用抗菌乳膏和其制备方法 | |
CN104338147A (zh) | 一种用于缓控释给药的软膏组合基质 | |
SK282578B6 (sk) | Lieková forma na dávkovanie kolagenázy na rany a spôsob jej výroby | |
Wang et al. | Sustained transdermal delivery of human growth hormone from niosomal gel: In vitro and in vivo studies | |
CN1985989A (zh) | 碱性成纤维生长因子聚乳酸缓释纳米微球凝胶及其制备方法 | |
RU2296571C1 (ru) | Ранозаживляющий состав и способ его получения | |
CN112533637A (zh) | 含有纳米分散体的静电纺丝纤维及其在治疗伤口中的用途 | |
Taguchi et al. | Evaluation of tumor tissue fixation effects of formulation modified Mohs pastes in mice and their water-absorbing properties | |
CN100450484C (zh) | 一种咪喹莫特混悬溶液及其凝胶剂 | |
AU2012275091B2 (en) | Topical formulations including lipid microcapsule delivery vehicles and their uses | |
Liu et al. | Research on liposomal hydrogels loaded with" Liu Zi Tang" compound Chinese medicine for the treatment of primary ovarian insufficiency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Jixiangshan beside yangtoukou flyover, No. 602, 817 Middle Road, Fuzhou City, 350000 Fujian Province Applicant after: Zhang Bingqi Address before: 250399 Room 701, Unit 1, Building 33, Yinfeng Mansion, University Road, Changqing District, Jinan City, Shandong Province Applicant before: Zhang Bingqi |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ren Jizhen Inventor after: Liu Sumei Inventor after: Fang Jing Inventor after: Zhang Bingqi Inventor before: Zhang Bingqi |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20200923 Address after: 266000 Shandong city of Qingdao province Jiangsu City Road No. 16 Applicant after: THE AFFILIATED HOSPITAL OF QINGDAO University Address before: Jixiangshan beside yangtoukou flyover, No. 602, 817 Middle Road, Fuzhou City, 350000 Fujian Province Applicant before: Zhang Bingqi |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201020 Termination date: 20210402 |
|
CF01 | Termination of patent right due to non-payment of annual fee |